
Apigenin vs Melatonin: Which Is Better for Sleep?
Should I take apigenin or melatonin for sleep?
Melatonin, dosed low. It scores 8.2 against apigenin's 6.7 and wins the sleep rows outright. The morning hangover apigenin markets against comes from taking too much, not from melatonin itself. Apigenin is the better buy only for anxious, wired evenings, and it carries its own next-day cost: emotional flatness.
- Melatonin 8.2 and a strong recommend. Apigenin 6.7 and worth trying. That is a wide gap, and on sleep it is real.
- Apigenin is sold as melatonin without the hangover. The grogginess it markets against is a dose problem: the melatonin report says higher doses mostly add next-morning grogginess without proportional benefit.
- Fix the dose instead of switching compounds. Burgess 2010 found 0.5 mg advanced the clock about as much as 3.0 mg, so the low dose is not a weaker version of the high one.
- Apigenin is not free of next-day cost either. Its report logs a reversible mood-blunting signal at chronic 100+ mg a day: emotional flatness, reduced motivation, anhedonia-like effects.
- No pure-apigenin sleep RCT exists. The human sleep signal is chamomile extract in older adults (Adib-Hajbaghery 2017), and chamomile carries luteolin, quercetin, bisabolol and more alongside apigenin.
- Melatonin's real risk is the bottle, not the molecule. Tested products ran from 83 percent below to 478 percent above their labeled content, and several contained serotonin (Erland 2017).
- Apigenin costs $15 to $35 a month. Melatonin is an ESTIMATED $3 to $8. Chamomile tea is about $5.
- Where apigenin wins: anxious, wired-at-bedtime evenings. Stress-resilience 4.5 against 1.5, mood 3.5 against 1.5.
At a Glance
Apigenin
- Efficacy 3.3
- Breadth 3.3
- Evidence 3.5
- Speed 3.5
- Durability 2.0
- Bioindividuality 2.8
- Safety Risk 1.6
- Side Effects 1.8
- Cost 2.0
- Effort 1.0
- Opportunity Cost 2.5
- Dependency 1.5
- Reversibility 1.5
- Sleep Quality
- Anxiety
- Stress Resilience
- Mood
Chamomile flavonoid, partial GABA-A benzodiazepine-site modulator. BioHarmony 6.7, worth trying.
Melatonin
- Efficacy 4.0
- Breadth 4.3
- Evidence 4.6
- Speed 4.0
- Durability 3.3
- Bioindividuality 4.2
- Safety Risk 1.5
- Side Effects 1.6
- Cost 1.3
- Effort 1.3
- Opportunity Cost 1.5
- Dependency 1.3
- Reversibility 1.3
- Circadian Rhythm
- Sleep Quality
- Pediatric
- Antioxidant
Circadian timing hormone acting at MT1 and MT2. BioHarmony 8.2, strong recommend.
Head-to-Head Verdict
| Use Case | Winner | Rationale |
|---|---|---|
| Sleep Quality | Melatonin | Melatonin 7.1 against apigenin 5.5, and the evidence decides it, not the gap. Ferracioli-Oda 2013 pooled 19 randomized trials: sleep latency down 7.06 minutes, total sleep time up 8.25 minutes, quality SMD 0.22. Apigenin's best human sleep signal is Adib-Hajbaghery 2017, chamomile in 60 older adults. The 25 to 50 mg capsule protocol is extrapolated from that. |
| Circadian Rhythm | Melatonin | Melatonin 7.8 against apigenin 2.0, the widest gap here and the one row where nothing substitutes. Burgess 2010 showed 0.5 mg advanced the clock about as much as 3.0 mg, Herxheimer 2002 supports it for jet lag, and Sack 2000 entrained blind people with no light cues. Apigenin has no human circadian data. If your clock is set wrong, apigenin is the wrong tool. |
| Pediatric | Melatonin | Melatonin 6.7 against apigenin 1.0, in supervised contexts only. Rossignol 2011 found sleep latency improved about 39 minutes and total sleep time about 44 minutes in autism trials, and Gringras 2017 backed prolonged-release melatonin in autistic children. Apigenin has no pediatric data. Melatonin still excludes young children without pediatric guidance, and gummies are an ingestion risk. |
| Anxiety | Tie | Even at 5.0 apigenin against 5.8 melatonin, because the scores describe different situations. Apigenin's case is chamomile in generalized anxiety: Amsterdam 2009 randomized 57 people to a greater HAM-A reduction than placebo, and Mao 2016 held symptoms lower without a clean relapse win. Melatonin's case is perioperative anxiety, a surgery week rather than a life. |
| Stress Resilience | Apigenin | Apigenin 4.5 against melatonin 1.5, the clearest reason to buy apigenin at all. Mild GABA-A modulation lowers acute arousal, which is the wired-at-bedtime problem melatonin does nothing for. The ceiling is low: no human stress-resilience trial used apigenin or chamomile as the primary intervention, so the 4.5 borrows from the anxiety trials. Melatonin's 1.5 means research-only, not failed. |
| Mood | Apigenin | Apigenin 3.5 against melatonin 1.5, with the sharpest caveat on this page attached. Amsterdam 2012 found an exploratory antidepressant signal in anxious-depressed humans, using chamomile extract. Against that, apigenin's report logs reversible mood blunting at chronic 100+ mg a day: flatness, low motivation, anhedonia-like effects. Same compound, separated mostly by dose and frequency. |
| Cognition Focus | Tie | The row this page turns on, and neither side earns it. Apigenin 2.5 against melatonin 1.5, both no-evidence scores: no human RCT tested cognitive endpoints for either. What each report does log is a next-day cost. Apigenin's is emotional flatness plus possible transient daytime focus impairment at sleep doses. Melatonin's is grogginess that scales with dose. Neither is hangover-free. |
| Antioxidant | Melatonin | Melatonin 6.0 against apigenin 3.5, which reverses the assumption that the plant compound is the antioxidant. Melatonin and its metabolites act in both water and lipid compartments and enter mitochondria. Apigenin's ROS scavenging and SOD or catalase upregulation, reviewed in Shukla 2010, stay in cells and rodents. Neither is a reason to buy either. |
| Longevity | Tie | Apigenin 3.0 against melatonin 1.5, and the honest verdict is neither. Apigenin's whole longevity pitch is CD38 inhibition: Escande 2013 inhibited CD38 and raised NAD+ in cells and mice. No human trial confirms NAD+ elevation at oral doses, and Javadi 2024 lands the same way for metabolic syndrome. Buying apigenin for NAD+ is buying a mouse result. |
Cost Comparison
| Intervention | Monthly Cost | Notes |
|---|---|---|
| Apigenin | $15 to $35 | Extracted from the report, priced 2026-09-08, ordinary retail channel at 25 to 50 mg of pure isolate 30 to 60 minutes before bed. That nightly trial sits inside the $15 to $35 band for isolate capsules.Chamomile tea is the cheaper route at about $5 a month, and it is also the form closer to the trials, because Mao 2016, Amsterdam 2009 and Adib-Hajbaghery 2017 all tested chamomile rather than isolated apigenin. The isolate costs more and has less human evidence behind it. |
| Melatonin | $3 to $8 | ESTIMATE, priced 2026-09-07, ordinary retail channel at 0.5 to 3 mg. The basis is about $0.11 per serving, with a third-party-tested 60-tablet 3 mg bottle at $10 to $13, which puts a nightly 0.5 to 3 mg dose at $3 to $8.Treat that as a channel estimate rather than a measured price. The only spend worth defending here is third-party testing, because untested products ran from 83 percent below to 478 percent above their labeled content (Erland 2017). |
| The difference | About $12 to $27 a month | Roughly $144 to $324 a year separates them, and melatonin is the cheap side. For a page about morning function that matters less than it looks, because the cheaper option is also the one with the meta-analytic sleep evidence.Where money does change the outcome: on melatonin, paying for a USP-Verified or third-party-tested product, since a mislabeled 478 percent overdose is the most likely way anyone actually gets a melatonin hangover. On apigenin, deciding between $5 tea and a $35 isolate that has no sleep RCT of its own. |
When to Switch
Judge these on different clocks. Melatonin is noticeable on night one, reaches full effect in 2 weeks, and carries a 2-week assessment window, so two weeks of correctly timed low dosing is a complete verdict. Apigenin is noticeable within about an hour, reaches full effect in 3 weeks, and carries a 3-week window. Both sets of figures are extracted from the reports, not estimated.
The apigenin protocol runs 3 to 4 nights a week rather than nightly, and that is deliberate. The mood-blunting signal tracks chronic daily use more than occasional use, so a nightly habit is the version most likely to cost you a morning.
Move from melatonin to apigenin when you have already tried 0.5 mg timed before your natural onset and the residue is still there at breakfast, or when the real problem is bedtime arousal rather than sleep timing. Stress-resilience 4.5 against 1.5 is the row that justifies it.
Move the other way, from apigenin to melatonin, when 25 to 50 mg does nothing after three weeks, when the fault turns out to be the clock rather than the nerves, when daytime motivation or emotional range starts flattening, or when cost decides it.
Do not run them together casually. The mechanisms do not overlap, a GABA-A modulator against a circadian signal, so stacking is coherent on paper. The contraindication lists disagree: apigenin's rules out concurrent benzodiazepines and other sedative-hypnotics, and melatonin's rules out concurrent sedatives or hypnotics.
If you stack anyway, do it with a clinician. Start melatonin at 0.5 mg alone, add apigenin at 25 mg later, and change one variable at a time. Otherwise a flat morning has two possible causes and you cannot tell them apart.
Who Should Pick What?
You take 5 or 10 mg of melatonin and wake up foggy
Melatonin
Cut the dose before you change the compound. Melatonin's own report says higher doses often add grogginess without proportional benefit, and Burgess 2010 found 0.5 mg advanced the circadian clock about as much as 3.0 mg. Drop to 0.5 mg, time it before your natural onset rather than at bedtime, and give it the 2-week window.
You lie in bed wired and rehearsing tomorrow
Apigenin
This is arousal, not timing, and it is the one place apigenin beats melatonin: stress-resilience 4.5 against 1.5, mood 3.5 against 1.5. Run the low-risk trial at 25 to 50 mg, 30 to 60 minutes before bed, 3 to 4 nights a week for 2 to 3 weeks, and track morning motivation as carefully as sleep latency.
Flying east across several time zones next week
Melatonin
Circadian-rhythm 7.8 against 2.0, and apigenin has no human circadian data to offer. Herxheimer 2002 found melatonin near destination bedtime effective for preventing or reducing jet lag. Take 0.5 to 5 mg at destination bedtime for several days. Nothing about a GABA-A modulator moves a clock.
You are on warfarin or another anticoagulant
Melatonin
Apigenin lists warfarin and other anticoagulants as a contraindication, alongside surgery scheduled within 2 weeks. That is the most actionable interaction on its page. Melatonin has no anticoagulant contraindication, though it does list concurrent fluvoxamine and concurrent sedatives, so still take the list to your prescriber.
You have bipolar disorder or bipolar-spectrum mood instability
Apigenin
Melatonin lists bipolar or bipolar-spectrum mood instability first among its contraindications. Apigenin does not, but it is not a free pass: chronic 100+ mg a day carries a reversible mood-blunting signal, which is the wrong direction for anyone managing mood. Keep the dose at 25 to 50 mg, keep it intermittent, and involve your prescriber.
Parent of an autistic child with insomnia, under a clinician
Melatonin
Pediatric 6.7 against 1.0. Rossignol 2011 reported sleep-onset latency improved about 39 minutes and total sleep time about 44 minutes, and Gringras 2017 supported prolonged-release melatonin in autistic children. Apigenin has no pediatric human data. Supervised use only, and store the bottle where a child cannot reach it.
You have ragweed, daisy or chamomile allergy
Melatonin
Asteraceae allergy is a listed apigenin contraindication and the source of its rare severe-allergy risk. That rules out tea, extract and isolate together. Melatonin has no botanical allergy exposure, so it is the default here provided none of its own exclusions apply to you.
Pregnant or breastfeeding
Tie
Neither, without a clinician. Pregnancy and lactation are listed contraindications on both reports. Apigenin adds in vitro uterotonic activity at high concentrations plus aromatase inhibition, and melatonin's prenatal score of 5.0 exists because the mechanism is interesting, not because a pregnancy-outcomes trial supports supplement use.
Taking apigenin for NAD+ and longevity
Tie
Neither is doing that job. Escande 2013 inhibited CD38 and raised NAD+ in cells and mice, and no human trial confirms it at oral supplement doses. Javadi 2024 found mostly preclinical support for metabolic syndrome too. Buy apigenin for evening calm if you want, but do not price it as a longevity compound.
Research Highlights
-
Mechanism Difference
These act on different systems, so they are complementary rather than redundant. Apigenin is a partial positive allosteric modulator at the GABA-A benzodiazepine site, with secondary preclinical CD38 inhibition, aromatase inhibition and NF-kB suppression. It lowers arousal.Melatonin is a timing signal at MT1 and MT2 receptors in the suprachiasmatic nucleus, shifting circadian phase and shortening sleep onset, with secondary antioxidant activity. It does not sedate. That is why apigenin can help a wired bedtime and melatonin cannot, and why melatonin fixes a clock apigenin cannot touch.
-
Safety Comparison
Two different exclusion lists that overlap in one place. Apigenin rules out pregnancy, lactation, estrogen-sensitive disease, surgery within 2 weeks, warfarin and other anticoagulants, benzodiazepines and other sedative-hypnotics, Asteraceae allergy, and alcohol or other CNS depressants taken at the same time.Melatonin rules out bipolar or bipolar-spectrum mood instability, pregnancy, lactation, young children without pediatric guidance, uncontrolled diabetes or morning hypoglycemia, fluvoxamine, concurrent sedatives or hypnotics, and autoimmune disease without clinician guidance. Pregnancy and lactation rule out both. Each also lists the other's sedative class as a caution.
-
Cost Comparison
Apigenin runs $15 to $35 a month at 25 to 50 mg of isolate, extracted from the report and priced 2026-09-08. Melatonin is an ESTIMATED $3 to $8 a month at 0.5 to 3 mg, based on about $0.11 per serving and a third-party-tested 60-tablet 3 mg bottle at $10 to $13.So the cheaper option is also the better-evidenced one, which is unusual. Chamomile tea at about $5 a month undercuts the isolate and sits closer to the trials that exist. On melatonin, the money worth spending is on third-party testing rather than on dose.
-
Next Morning Function
Apigenin is sold as melatonin without the hangover. The premise is half right. Melatonin's report says higher doses often add next-morning grogginess without proportional benefit, and Burgess 2010 found 0.5 mg advanced the clock about as much as 3.0 mg. The grogginess is a dose decision, and the fix costs nothing.The other half is wrong. Apigenin's report logs a reversible mood-blunting signal at chronic 100+ mg a day: emotional flatness, reduced motivation, anhedonia-like effects, appearing less often at 25 to 50 mg intermittent use. Its cognition-focus score is 2.5 partly because GABA-A modulation at sleep doses may transiently impair daytime focus. Different morning cost, not no morning cost.
-
Editorial Verdict
Take melatonin at 0.5 mg, timed before your natural onset. It scores 8.2 against apigenin's 6.7, leads sleep-quality 7.1 to 5.5 and circadian rhythm 7.8 to 2.0, costs a quarter as much, and rests on 19 pooled randomized trials (Ferracioli-Oda 2013) rather than on chamomile studies read across to a different molecule.Apigenin is worth buying for one situation: an anxious, wired bedtime where the clock is fine and the nervous system is not. Stress-resilience 4.5 against 1.5 is the row that earns it. Buy the chamomile form, keep it to 25 to 50 mg on 3 to 4 nights a week, and watch your daytime motivation.
Frequently Asked Questions
- Is apigenin really melatonin without the hangover?
- Half true. The melatonin hangover is a dose artifact: melatonin's report says higher doses often add next-morning grogginess without proportional benefit, and Burgess 2010 showed 0.5 mg shifted the clock about as much as 3.0 mg. Drop the dose and the hangover usually goes with it.Apigenin has its own next-day cost. Its report logs a reversible mood-blunting signal at chronic 100+ mg a day, meaning emotional flatness, low motivation and anhedonia-like effects, less common at 25 to 50 mg taken 3 to 4 nights a week.
- Which is better for sleep, apigenin or melatonin?
- Melatonin, on both the score and the evidence. Sleep-quality 7.1 against 5.5, and Ferracioli-Oda 2013 pooled 19 randomized trials showing sleep latency down 7.06 minutes and total sleep time up 8.25 minutes.Apigenin has no pure-apigenin sleep RCT at all. Its closest human data is Adib-Hajbaghery 2017, chamomile extract improving PSQI in 60 older adults, and chamomile carries luteolin, quercetin, bisabolol and other actives alongside apigenin.
- How much melatonin should I take to avoid morning grogginess?
- Start at 0.5 mg and time it before your natural melatonin onset rather than at bedtime. Burgess 2010 found 0.5 mg advanced the circadian clock about as much as 3.0 mg, so the low dose is not a weaker version of the high one. The report's own range is 0.5 to 3 mg.Buy a USP-Verified or third-party-tested product, because a dose you cannot trust is the most likely reason a morning goes badly. Erland 2017 found products from 83 percent below to 478 percent above their label, and Cohen 2023 found most US gummies missed theirs.
- Does apigenin cause next-day side effects?
- It can. The signal in apigenin's report is reversible mood blunting at chronic higher doses, especially 100+ mg a day: emotional flatness, reduced motivation and anhedonia-like effects. Its cognition-focus subrating of 2.5 also notes that GABA-A modulation at sleep doses may transiently impair daytime focus in some people.The rate is lower at 25 to 50 mg used intermittently, which is why the report's own protocol runs 3 to 4 nights a week rather than nightly.
- Can I take apigenin and melatonin together?
- Only with a clinician. The mechanisms do not overlap, a GABA-A modulator against a circadian signal, so on paper stacking is coherent. The contraindication lists say otherwise: apigenin's rules out concurrent benzodiazepines and other sedative-hypnotics, and melatonin's rules out concurrent sedatives or hypnotics.If you stack anyway, start melatonin at 0.5 mg alone for its full 2-week window, then add 25 mg of apigenin, and change one variable at a time. Otherwise a flat morning has two possible causes and you cannot tell which.
- Which one is cheaper?
- Melatonin, by roughly $12 to $27 a month. Apigenin runs $15 to $35 for 25 to 50 mg of isolate, extracted from the report and priced 2026-09-08. Melatonin is an ESTIMATED $3 to $8 at 0.5 to 3 mg, based on about $0.11 a serving. Chamomile tea sits between them at about $5 a month and is closer to the form the human trials actually used.
- How long before I know whether either is working?
- Melatonin is noticeable on night one, reaches full effect in 2 weeks and carries a 2-week assessment window. Two weeks of correctly timed low dosing is a complete verdict.Apigenin is noticeable within about an hour, reaches full effect in 3 weeks and carries a 3-week window, run at 25 to 50 mg on 3 to 4 nights a week. Track sleep latency and morning motivation together, because motivation is the number apigenin puts at risk.
- Who should not take either one?
- Pregnancy and lactation rule out both. Apigenin also rules out estrogen-sensitive disease, surgery scheduled within 2 weeks, warfarin and other anticoagulants, Asteraceae allergy including ragweed and daisy, and combining with alcohol or other CNS depressants.Melatonin also rules out bipolar or bipolar-spectrum mood instability, young children without pediatric guidance, uncontrolled diabetes or morning hypoglycemia, fluvoxamine, and autoimmune disease without clinician guidance. Keep melatonin gummies away from children.
Evidence Sources
- Systematic review Meta-analysis: melatonin for the treatment of primary sleep disorders, PLoS One (2013) 19 randomized trials. Sleep-onset latency down about 7 minutes, total sleep time up about 8 minutes. The anchor for melatonin's 7.1 sleep-quality score.
- RCT Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg, Journal of Clinical Endocrinology and Metabolism (2010) 0.5 mg advanced the circadian clock about as much as 3.0 mg. The reason a low dose is the answer to morning grogginess.
- Systematic review Effects of exogenous melatonin on sleep: a meta-analysis, Sleep Medicine Reviews (2005) Pooled analysis showing shorter sleep latency, higher sleep efficiency and longer total sleep time.
- Systematic review Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Medicine Reviews (2017) Supports melatonin for delayed sleep phase and circadian rhythm disorders more than for general insomnia.
- Systematic review Melatonin for the prevention and treatment of jet lag, Cochrane Database of Systematic Reviews (2002) Melatonin taken near destination bedtime was effective for preventing or reducing jet lag across multiple time zones.
- RCT Entrainment of free-running circadian rhythms by melatonin in blind people, New England Journal of Medicine (2000) Melatonin entrained the free-running rhythms of blind people with no light cues to set their clocks.
- Systematic review Melatonin in autism spectrum disorders: a systematic review and meta-analysis, Developmental Medicine and Child Neurology (2011) Sleep-onset latency improved about 39 minutes and total sleep time about 44 minutes versus placebo in autism-spectrum sleep trials.
- RCT Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder, Journal of the American Academy of Child and Adolescent Psychiatry (2017) Prolonged-release melatonin improved total sleep time and sleep-onset latency in autistic children.
- Observational Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content, Journal of Clinical Sleep Medicine (2017) Products contained from 83 percent below to 478 percent above labeled melatonin content, and several also contained serotonin.
- Observational Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US, JAMA (2023) Most US melatonin gummies tested did not match their labeled dose, ranging widely above and below label.
- RCT The effects of chamomile extract on sleep quality among elderly people: A clinical trial, Complementary Therapies in Medicine (2017) 60 older adults randomized. Chamomile extract improved PSQI sleep quality versus control. The closest thing apigenin has to a sleep trial, and it is chamomile.
- RCT A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita extract therapy for generalized anxiety disorder, Journal of Clinical Psychopharmacology (2009) 57 randomized. Chamomile produced a greater HAM-A reduction than placebo, supporting modest anxiolytic activity.
- RCT Long-term chamomile therapy of generalized anxiety disorder: A randomized clinical trial, Phytomedicine (2016) 179 entered the open-label phase and 93 responders were randomized. Chamomile maintained lower GAD symptoms, but the relapse hazard was not statistically significant.
- RCT Chamomile (Matricaria recutita) May Have Antidepressant Activity in Anxious Depressed Humans: An Exploratory Study, Alternative Therapies in Health and Medicine (2012) Exploratory antidepressant signal in anxious-depressed humans using chamomile extract, not isolated apigenin.
- Systematic review The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials, Clinical Nutrition Research (2024) Nine of ten included trials concluded anxiety reduction. Supports chamomile, not isolated apigenin.
- Preclinical Flavonoid apigenin is an inhibitor of the NAD+ase CD38, Diabetes (2013) Cell and mouse study. Apigenin inhibited CD38, raised NAD+ and improved metabolic parameters in obese mice. No human confirmation.
- Systematic review Role of apigenin in targeting metabolic syndrome: A systematic review, Iranian Journal of Basic Medical Sciences (2024) Mostly preclinical support. Not a human efficacy close for NAD+, sleep or anxiety claims.
- Review Apigenin: A Promising Molecule for Cancer Prevention, Pharmaceutical Research (2010) Reviews apigenin's antioxidant and anti-inflammatory preclinical mechanisms. The basis for its 3.5 antioxidant score.
- Review Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity, Advances in Nutrition (2017) Confirms chamomile and parsley as flavone sources and highlights low, variable oral bioavailability.
- Authority Chamomile: Usefulness and Safety, NCCIH (2024) Insufficient evidence for most conditions, preliminary anxiety and depression signals, very little insomnia evidence, plus allergy and interaction caveats.
Glossary
Quick reference for the medical and technical terms used in this comparison.
- GABA-A Gamma-Aminobutyric Acid Type A Receptor
- The brain's main inhibitory receptor. Apigenin binds partially at its benzodiazepine site, which lowers arousal. Melatonin does not touch it.
- PAM Positive Allosteric Modulator
- A compound that boosts a receptor's response to its own signal instead of activating it directly. Apigenin is a partial one at GABA-A, which is why it calms rather than sedates.
- MT1 and MT2 Melatonin Receptors 1 and 2
- The receptors in the suprachiasmatic nucleus that melatonin acts on to shift circadian phase and shorten sleep onset.
- DLMO Dim-Light Melatonin Onset
- The time your own melatonin starts rising in the evening. Dosing before it produces the largest phase advance, which is the timing lever in Burgess 2010.
- SCN Suprachiasmatic Nucleus
- The hypothalamic master clock. Melatonin's target, and the reason it fixes timing problems that a calming compound cannot.
- PSQI Pittsburgh Sleep Quality Index
- A standard self-reported sleep-quality questionnaire. The endpoint chamomile extract improved in Adib-Hajbaghery 2017.
- HAM-A Hamilton Anxiety Rating Scale
- The clinician-scored anxiety scale chamomile beat placebo on in Amsterdam 2009.
- GAD Generalized Anxiety Disorder
- The diagnosis in the chamomile trials that carry apigenin's anxiety score, including Mao 2016.
- CD38 Cluster of Differentiation 38
- An enzyme that consumes NAD+. Apigenin inhibited it in cells and mice (Escande 2013), which is the whole basis of its longevity pitch and none of it is human.
- SMD Standardized Mean Difference
- A way of pooling effect sizes across trials that measured things differently. Melatonin's sleep-quality SMD was 0.22 in Ferracioli-Oda 2013, which is small.